Skip to content

Study on the Clinical Outcomes of ABO-Incompatible Living Donor Liver Transplantation

Study on the Clinical Outcomes of ABO-Incompatible Living Donor Liver Transplantation

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07273448
Enrollment
100
Registered
2025-12-09
Start date
2014-01-01
Completion date
2029-12-31
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ABO Incompatibility, Liver Transplant Surgery, Living Donor Liver Transplantation

Brief summary

Evaluate the postoperative survival rate and incidence of rejection in patients undergoing ABO-incompatible living donor liver transplantation; analyze the occurrence of secondary endpoint events such as postoperative vascular complications and biliary complications; and explore relevant risk factors affecting prognosis.

Detailed description

Prospective and retrospective

Interventions

None listed

Sponsors

Zhi-Jun Zhu
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Underwent ABO-incompatible living donor liver transplantation 2. Complete and intact clinical and follow-up data

Exclusion criteria

1. Non-primary liver transplantation 2. Combined other organ transplantation 3. Incomplete clinical data or loss to follow-up

Design outcomes

Primary

MeasureTime frame
Postoperative survival rateMinimum follow-up period of 1 year postoperatively.
incidence of acute rejectionWithin 1 year postoperatively

Secondary

MeasureTime frame
Vascular complicationsWithin 1 year postoperatively
Biliary complicationsWithin 1 year postoperatively

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026